{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:18:58Z","timestamp":1787962738539,"version":"build-2784847793"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jpeds.2017.02.074","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T13:01:04Z","timestamp":1490274064000},"page":"106-111.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Bradycardia Associated with Prednisolone in Children with Severe Kawasaki Disease"],"prefix":"10.1016","volume":"185","author":[{"given":"Akito","family":"Nagakura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2017.02.074_bib0010","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial","volume":"379","author":"Kobayashi","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2017.02.074_bib0015","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease","volume":"113","author":"Kobayashi","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2017.02.074_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2011.07.018","article-title":"Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis","volume":"309","author":"Vasheghani-Farahani","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jpeds.2017.02.074_bib0025","doi-asserted-by":"crossref","first-page":"e778","DOI":"10.1542\/peds.2006-0029","article-title":"Sinus bradycardia after intravenous pulse methylprednisolone","volume":"119","author":"Akikusa","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2017.02.074_bib0030","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/MPH.0b013e31815dcfeb","article-title":"Glucocorticoid-associated bradycardia","volume":"30","author":"van der Gugten","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2017.02.074_bib0040","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/pch\/16.8.479","article-title":"Steroid pulse therapy for Kawasaki disease unresponsive to additional immunoglobulin therapy","volume":"16","author":"Miura","year":"2011","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.jpeds.2017.02.074_bib0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s004310051050","article-title":"Tachycardia as a potential risk indicator for coronary arterial lesions in Kawasaki disease","volume":"158","author":"Suzuki","year":"1999","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jpeds.2017.02.074_bib0050","series-title":"Systemic inflammatory response syndrome can be a risk factor for coronary artery lesion in Kawasaki disease","author":"Tomobe","year":"2015"},{"key":"10.1016\/j.jpeds.2017.02.074_bib0055","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(10)62226-X","article-title":"Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies","volume":"377","author":"Fleming","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2017.02.074_bib0060","series-title":"Electrocardiogram in infants and children: a systematic approach","author":"Garson","year":"1983"},{"key":"10.1016\/j.jpeds.2017.02.074_bib0065","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2017.02.074_bib0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/ped.12317","article-title":"Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version)","volume":"56","author":"Saji","year":"2014","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jpeds.2017.02.074_bib0075","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-4632.2004.02587.x","article-title":"Cardiovascular effects of corticosteroid pulse therapy: a prospective controlled study on pemphigus patients","volume":"44","author":"Jain","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jpeds.2017.02.074_bib0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02715692","article-title":"Holter monitoring in ankylosing spondylitis patients during methylprednisolone pulse therapy","volume":"3","author":"Nasswetter","year":"1984","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jpeds.2017.02.074_bib0085","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/adc.2004.062299","article-title":"Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease","volume":"90","author":"Miura","year":"2005","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2017.02.074_bib0090","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3181\/00379727-173-41653","article-title":"Acute cardiovascular response to a single large intravenous dose of methylprednisolone and its effects on the responses to norepinephrine and isoproterenol","volume":"173","author":"Hall","year":"1983","journal-title":"Proc Soc Exp Biol Med"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347617303402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347617303402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T04:27:43Z","timestamp":1535948863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347617303402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":16,"alternative-id":["S0022347617303402"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2017.02.074","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bradycardia Associated with Prednisolone in Children with Severe Kawasaki Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2017.02.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}